2022年12月31日

2022年12月30日医疗扫描技术公司iThera医疗宣布成功关闭€1300万投资,由Trumpf公司一步步与共同参与的基金除了现有投资者资本矩阵最大经济产量,Wachstumsfonds拜仁,BayBG, Fluxunit,福尔克Strascheg控股和欧美国家。资金将推动公司的持续创新和商业化的新颖的医学成像技术,具有特定目标的技术转化为常规临床环境和全球临床医生提供一个强大的新的诊断工具。在临床实践中,广泛的诊断程序是必不可少的临床医生诊断疾病和监测治疗反应。然而,许多领域有一个未满足的需要准确、客观、定量的方法。iThera医疗开发了多光谱光声层析成像(MSOT),一个突破成像技术,利用光声效应——描述了光能量转化为声波可视化光学对比,在深层组织的高分辨率。MSOT已经展示了其潜在的临床价值在各种各样的疾病领域,目前主要用于临床研究全球学术医院。“下一代”设备完成的翻译研究常规临床使用,iThera医疗签署了€1300万一轮融资。从这一轮融资产生的收益将用于开发新一代MSOT设备优化常规临床使用,获得监管部门的批准在欧洲和美国部署(CE -和fda的批准),并显著扩大临床证据优先级临床适应症。共同投资的共同基金之际,iThera医疗的股权部分成功应用程序授予地平线欧洲共同加速器项目。这个项目使用了一个独特的混合grant-equity计划基金欧洲开拓创新。 In addition to a €2.5 million grant to support technology development, the European Union will also directly invest in iThera Medical via the EIC Fund. Ulrich Kruse, Investment Manager of Trumpf Venture, commented, “iThera Medical’s technology is positioned to be the next breakthrough in medical imaging. As a company with deep roots in photonics and medical technology, we are thrilled to support the continued development of MSOT and anticipate an impactful launch into wider medical imaging markets.” Christian Wiest, CEO and co-founder of iThera Medical, said, “This funding round is the next major step to translate our MSOT technology from a tool in research to a diagnostic asset in a clinical setting, where we believe it will be a game-changer for millions of patients worldwide.” Surya Fackelmann, Investment Officer of the European Investment Bank, said, “The EIC Accelerator program allows the European Union to identify ambitious companies whose innovations have immense potential to benefit the European economy and populace. The direct investment in iThera Medical by the EIC Fund will help deliver this exciting new technology to clinics and is part of our larger goal to finance Europe’s future.”